This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Browse
Vladonix
Khavinson thymic tetrapeptide.
Aliases (3)
Glu-Asp-Pro-Gly · thymus-derived tetrapeptide · Khavinson thymus regulator
TYPICAL DOSE
—
ROUTE
—
CYCLE
—
STORAGE
—
Overview
What is Vladonix?
Khavinson thymic tetrapeptide. Same evidence + bioavailability concerns as the rest of the catalog. WATCH-LIST.
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
Was this helpful?
Your feedback shapes what we research deeper.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
Loading…
✎
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.
Discussion — click to load ▸
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources
Related compounds
Cross-referenced from VladonixThymalin
OTHER
Peptide
LOW
Thymogen
WATCH-LIST
Khavinson short-peptide thymus bioregulator. Synthetic dipeptide (Glu-Trp) developed at the St. Petersburg Institute of Bioregulation and Gerontology in the 1980s. Marketed in Russia as immunomodulator.
LOW
Cortexin
SKIP-FOR-NOW
Russian-peptide / animal-derived low-molecular-weight peptide complex (bovine cerebral cortex hydrolysate, ~1-10 kDa fraction); Khavinson-network bioregulator family
LOW